An immunoassay method and system

By reflecting light multiple times in the magnetic nanoparticle immunoassay reagent under an AC magnetic field and extracting magneto-optical signals, combining the ratio of the second harmonic to the DC component, the detection sensitivity and detection of existing magneto-optical immunoassay methods are solved. The problem of height limit achieves high-precision and high-sensitivity magneto-optical immune detection without cleaning steps.

CN115326716BActive Publication Date: 2024-11-19HUAZHONG UNIV OF SCI & TECH +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202211019708.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-08-24
Publication Date
2024-11-19
Estimated Expiration
2042-08-24

AI Technical Summary

Technical Problem

The existing magneto-optical immunoassay methods have problems with low detection sensitivity and high detection limits, especially due to the increased detection limits caused by interference from unbound fluorescent quantum dots and unbound immune complexes.

Method used

By reflecting incident light multiple times in the functional magnetic nanoparticle immunoassay reagent under an alternating magnetic field, converting the emitted light into a voltage signal, extracting the magneto-optical signal, and comparing it with the signal after mixing the solution to be tested, The ratio of the second harmonic component to the DC component determines the existence of the molecule to be tested, avoiding the cleaning step and improving the detection accuracy and sensitivity.

Benefits of technology

The concentration of magnetic nanoparticles detected in a short time is at least three orders of magnitude higher, which reduces the lower limit of detection concentration, improves the accuracy and sensitivity of immune detection, and simplifies the operation process, avoids water interference and failure. Effect of the conjugate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115326716B_ABST
    Figure CN115326716B_ABST
Patent Text Reader

Abstract

The present invention discloses an immunoassay method and system, which belongs to the field of nanomaterial testing. The method includes: making the incident light reflect multiple times in the functional magnetic nanoparticle immunoassay reagent under the stimulation of an alternating magnetic field; converting the outgoing light after multiple reflections into a voltage signal, and extracting the magneto-optical signal corresponding to the immunoassay reagent; mixing the immunoassay reagent with the solution to be tested, making the incident light reflect multiple times in the mixed solution under the stimulation of an alternating magnetic field; converting the outgoing light after multiple reflections into a voltage signal, and extracting the magneto-optical signal corresponding to the mixed solution; when the difference between the magneto-optical signal corresponding to the immunoassay reagent and the magneto-optical signal corresponding to the mixed solution exceeds a preset threshold, it is determined that the target molecule to be tested is contained in the solution to be tested. The present invention can improve the lower limit of the detection concentration of the molecule to be tested, improve the accuracy and sensitivity of immunoassay; it has the convenience of no washing, and is simpler to operate than the existing magneto-optical immunoassay method.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of nano material testing, and more specifically, relates to an immunoassay method and system. Background Art

[0002] Immunoassays use a variety of markers to measure antibodies or antigens. The most commonly used methods are enzyme-linked immunosorbent assays, radioimmunoassays, and real-time polymerase chain reactions. Recently, magnetic immunoassays have received attention. Magnetic nanoparticles can be used as markers for analytes in immunoassays due to their unique magnetic properties. The magnetic properties of magnetic nanoparticles can be used to characterize the detection characteristics of the molecules to be tested that interact with them. The magnetic-related quantities that are currently widely studied include magnetic relaxation, residual magnetization, AC magnetic susceptibility, saturation magnetization, and Brownian relaxation time. The use of specific functional groups in the solution can bind the molecules to be tested and the magnetic nanoparticles together, which will change the magnetic information of the magnetic nanoparticles. The changes in the magnetic response of the magnetic nanoparticles measured by the sensor are related to the concentration of the molecule to be tested.

[0003] Optical measurement methods have outstanding advantages such as non-contact, high sensitivity and high precision. The magneto-optical effect is a new method that can measure the magnetic information of magnetic nanoparticles. When a magnetic field is applied to a magnetic fluid, the magnetic nanoparticles will gather into chain-like clusters along the direction of the magnetic field, thus showing anisotropic properties. When light propagates in a magnetized magnetic fluid, a series of magneto-optical effects will be generated, causing the magneto-optical response signal to change. The intensity of the magneto-optical response signal is related to the concentration information of the magnetic fluid, so immune detection can be achieved by detecting the intensity of the magneto-optical effect.

[0004] The commonly used magneto-optical immunoassay methods at present include magnetic fluorescent nanoprobe detection and magnetic microparticle chemiluminescence immunoassay. In the magnetic fluorescent nanoprobe detection, unbound fluorescent quantum dots will produce a certain fluorescence intensity, which interferes with the detection of the conjugate and requires magnetic field separation. The magnetic microparticle chemiluminescence immunoassay requires washing after the antigen-antibody reaction is completed to remove substances that are not bound to the immune complex. The washing process will reduce the labeled analyte, resulting in an increase in the detection limit. Summary of the invention

[0005] In view of the above defects or improvement needs of the prior art, the present invention provides an immunoassay method and system, the purpose of which is to increase the lower limit of the concentration of the molecules to be detected and achieve magneto-optical immunoassay with higher accuracy and sensitivity.

[0006] To achieve the above object, according to one aspect of the present invention, there is provided 1. an immunoassay method, comprising:

[0007] S1. causing the incident light to be reflected multiple times in the functional magnetic nanoparticle immunoassay reagent under the stimulation of an alternating magnetic field;

[0008] S2. converting the emitted light after multiple reflections into a voltage signal and extracting the magneto-optical signal corresponding to the immunoassay reagent;

[0009] S3. The immunoassay reagent is mixed with the test solution, so that the incident light is reflected multiple times in the mixed solution under the excitation of the AC magnetic field; the incident light and the AC magnetic field are the same as step S1;

[0010] S4. converting the emitted light after multiple reflections into a voltage signal, and extracting the magneto-optical signal corresponding to the mixed solution;

[0011] S5. When the difference between the magneto-optical signal corresponding to the immunoassay reagent and the magneto-optical signal corresponding to the mixed solution exceeds a preset threshold, it is determined that the test solution contains the target molecule.

[0012] Furthermore, the magneto-optical signal is the ratio of the second harmonic component and the direct current component in the voltage signal.

[0013] Furthermore, the method also includes passing the incident light through a polarizer to form horizontally polarized light.

[0014] Furthermore, the AC excitation magnetic field is perpendicular to the propagation direction of the incident light.

[0015] Furthermore, the incident light is a laser with a wavelength of 520 nm.

[0016] According to another aspect of the present invention, there is provided an immunoassay system, comprising: a laser, a polarizer, a coil, an optical liquid chamber, a photodetector and a computer;

[0017] A laser for generating incident light;

[0018] Polarizer, used to change the polarization direction of incident light;

[0019] A coil for generating an AC excitation magnetic field;

[0020] An optical liquid chamber is used to hold a functional magnetic nanoparticle immunoassay reagent or a mixed solution of an immunoassay reagent and a solution to be tested, so that the incident light is reflected multiple times in the functional magnetic nanoparticle immunoassay reagent or the mixed solution under the excitation of an alternating magnetic field; the structure of the optical liquid chamber is a cubic container with reflectors plated on the front and back surfaces;

[0021] A photodetector, used to convert the outgoing light after multiple reflections into a voltage signal;

[0022] The computer is used to extract the magneto-optical signals corresponding to the immunoassay reagent and the mixed solution; when the difference between the magneto-optical signal corresponding to the immunoassay reagent and the magneto-optical signal corresponding to the mixed solution exceeds a preset threshold, it is determined that the target molecule is contained in the test solution.

[0023] Furthermore, the AC excitation magnetic field generated by the coil is perpendicular to the propagation direction of the incident light generated by the laser.

[0024] In general, compared with the prior art, the above technical solution conceived by the present invention can achieve the following beneficial effects.

[0025] (1) Compared with the AC sensor of the traditional detection scheme, the concentration of magnetic nanoparticles that can be detected by the magneto-optical detection system in a shorter time is at least three orders of magnitude smaller. Based on the existing magneto-optical effect, the present invention enables light to be reflected multiple times in the magnetic fluid, thereby increasing the optical path and significantly improving the intensity of the magneto-optical signal. This can further increase the lower limit of the detection concentration of the molecules to be detected and improve the accuracy and sensitivity of immunoassays.

[0026] (2) The present invention uses the ratio of the second harmonic amplitude to the DC component to characterize the magneto-optical signal. Experimental results show that the second harmonic generated by pure water under AC magnetic field excitation is negligible. Therefore, the magneto-optical signal used in this method has nothing to do with the anti-magnetism of water. Therefore, the interference of water on the detection result can be ignored, and the mixed solution has the convenience of no need to wash. Since the unbound analyte has no effect on the size of the magneto-optical signal, there is no need to wash the mixed solution after the antigen-antibody immune reaction occurs, and it can be directly detected, which is simpler to operate than the existing magneto-optical immunoassay method. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 It is a diagram of the magneto-optical immune detection device of the present invention;

[0028] Figure 2 is the change of magneto-optical signal of magnetic nanoparticle solution with different concentrations as the magnetic field changes;

[0029] Figure 3 It is the change of magneto-optical signal with magnetic field under different reflection times;

[0030] Figure 4 It is the change of magneto-optical signal of magnetic nanoparticles of different particle sizes with magnetic field. DETAILED DESCRIPTION

[0031] In order to make the purpose, technical solutions and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention. In addition, the technical features involved in the various embodiments of the present invention described below can be combined with each other as long as they do not conflict with each other.

[0032] In order to solve the technical problems of low efficiency and low detection sensitivity of the previous immunoassay method based on the magneto-optical effect, the present invention provides an immunoassay method based on an optical liquid cavity, the overall idea of ​​which is to use the multiple reflections of light in the optical liquid cavity to increase the ratio of the second harmonic amplitude of the magneto-optical response signal to the DC component, thereby reducing the lower limit of the concentration in the immunoassay. Compare the signals of the immunoassay reagent and the mixed solution. If the signal difference exceeds the threshold, it can be determined that the solution to be tested contains the target molecule. Due to the anti-magnetism of water, when AC excitation is applied to the magnetic nanoparticle solution, certain harmonic interference will be generated. However, the experimental results show that the second harmonic generated by pure water under AC magnetic field excitation can be ignored. Therefore, the magneto-optical signal used in this method has nothing to do with the anti-magnetism of water, so the interference of water on the detection result can be ignored. The mixed solution has the convenience of no washing, so the operation is relatively simple; the use of optical measurement technology to detect magnetic signals can improve the sensitivity of detection and achieve rapid detection.

[0033] The method of the present invention specifically comprises:

[0034] S1. Coating the antibody (antigen) of the object to be tested with magnetic nanoparticles to form a magnetic nanoparticle immune complex, and then preparing a functional magnetic nanoparticle immunoassay reagent. The incident light is reflected multiple times in the functional magnetic nanoparticle immunoassay reagent under the stimulation of the AC magnetic field;

[0035] Specifically, a laser with a wavelength of 520nm is used to generate laser light for detecting liquid concentration. At this wavelength, water has a low absorption rate for light. The wavelengths at which water has a low absorption rate and a large magneto-optical signal can also be comprehensively considered, thereby reducing the loss of light due to absorption when passing through the magnetic fluid while enhancing the magneto-optical signal.

[0036] Magnetic nanoparticles under the action of a magnetic field exhibit anisotropy. When light passes through a magnetic nanoparticle solution, both the absorption coefficient and the scattering coefficient change, thereby changing the transmittance of the incident light. The attenuation of light in a conventional solution satisfies the linear absorption law, namely the Lambert law:

[0037] I=I 0 exp(-αL)

[0038] Among them, I 0and I are the incident light intensity and the outgoing light intensity, respectively, L is the distance traveled by the light in the solution, and α is the attenuation coefficient. According to the magneto-optical signal obtained experimentally in the present invention, the above absorption law is corrected to obtain the relationship between the outgoing light intensity and the incident light intensity:

[0039] I=I 0 exp[-α(H)L]

[0040] Where H is the excitation magnetic field. According to Taylor's formula,

[0041]

[0042] From the above formula, we can know that when the applied excitation magnetic field is a sinusoidal AC field H = H 0 When sinωt, the emitted light signal will contain various harmonics. Changing the concentration of the magnetic nanoparticle solution, the intensity of the incident light and other parameters will change the corresponding harmonic amplitude. The second harmonic is used in the present invention because the second harmonic amplitude is the largest among all harmonics, and the harmonic component is positively correlated with the distance of the light passing through the magnetic nanoparticle solution under the action of the magnetic field. The ratio of the second harmonic to the DC component is used as the final magneto-optical signal, which can eliminate the difference in the detection results caused by different incident light intensities.

[0043] In order to distinguish the magneto-optical effect produced by the change in transmittance under the action of a magnetic field mentioned in the present invention from the traditional magneto-optical birefringence effect and magneto-optical Faraday effect, the length of the liquid container used is explained. The magneto-optical signal obtained by the magneto-optical birefringence effect comes from the phase difference The magneto-optical signal obtained by the magneto-optical Faraday comes from the rotation angle θ. The phase difference and rotation angle can be calculated by taking the sine or cosine of θ and θ. The proportional relationship between θ and the distance traveled by light in the magnetic fluid is applicable to the range of 0 to π / 2, so the thickness of the liquid container is limited to the order of μm. However, the distance traveled by the optical liquid cavity in the present invention is in the order of mm, so it is not suitable for the traditional magneto-optical birefringence effect and magneto-optical Faraday effect, which is explained by the change of transmittance.

[0044] When horizontally polarized light is reflected multiple times in a magnetic fluid under the excitation of an alternating magnetic field, the distance traveled by the light in the magnetic fluid increases with the increase in the number of reflections, and the magneto-optical signal is positively correlated with the distance traveled by the light in the magnetic fluid, so the magneto-optical signal will be greatly improved. The distance traveled by the light can also be increased by increasing the thickness of the cuvette, but the volume of the cuvette and the volume of the consumed solution will increase, the cost will increase, and it is not conducive to miniaturization and integration. Preferably, the AC excitation magnetic field is perpendicular to the propagation direction of the incident light, so that a stronger signal can be obtained.

[0045] S2. converting the emitted light after multiple reflections into a voltage signal and extracting the magneto-optical signal corresponding to the immunoassay reagent;

[0046] By processing the voltage signal, the DC component V 0 and the second harmonic amplitude V 2f , where f represents the excitation frequency of the AC magnetic field. The magneto-optical signal s used for analysis is V 2f / V 0 , thus eliminating the influence of different incident light intensities. The magneto-optical signals mentioned in the present invention refer to the ratio of the second harmonic amplitude to the DC component in the photovoltage.

[0047] S3. Mixing the immunoassay reagent with the antigen (antibody) to be tested, forming an antigen-antibody-magnetic nanoparticle conjugate after an immune reaction, and causing the incident light to be reflected multiple times in the mixed solution under the excitation of the AC magnetic field; the incident light and the AC magnetic field are the same as in step S1;

[0048] S4. converting the emitted light after multiple reflections into a voltage signal, and extracting the magneto-optical signal corresponding to the mixed solution;

[0049] S5. The magneto-optical signal of the immunoassay reagent is only related to the magnetic nanoparticles, while the magneto-optical signal of the mixed solution contains the total characteristic information of the unbound magnetic nanoparticles and the conjugates that produce immune reactions with the antigen (antibody) to be tested. The magneto-optical signal is related to the total particle size of the magnetic nanoparticles and their conjugates. Therefore, when the difference between the magneto-optical signal corresponding to the immunoassay reagent and the magneto-optical signal corresponding to the mixed solution exceeds a preset threshold, it is determined that the target molecule to be tested is contained in the test solution.

[0050] If the magneto-optical signal s of the functional magnetic nanoparticle solution 1 Magneto-optical signal of mixed solution 2 If the difference exceeds the threshold, the surface solution contains the target molecule. By changing the specific antibody (antigen) on the surface of the functional magnetic nanoparticles, different types of antigen (antibody) detection can be achieved.

[0051] Since the magneto-optical signal is only related to the particles containing magnetic nanoparticles, the unbound antigen (antibody) to be detected will not affect the detection result, so the immunoassay method proposed in the present invention is free of washing.

[0052] Example 1:

[0053] Compare the magneto-optical signals of magnetic nanoparticle solutions with different concentrations. Figure 2The figure shows the curves of the magneto-optical signal changing with the AC excitation magnetic field amplitude when the concentrations of the magnetic nanoparticle solution are 100 μg / ml, 10 μg / ml, 1 μg / ml and distilled water, respectively. It can be seen that when the AC excitation magnetic field amplitude is the same, the magneto-optical signal increases with the increase of the concentration of the magnetic nanoparticle solution.

[0054] Example 2:

[0055] Compare the magneto-optical signals with different reflection times. Figure 3 As shown, n is the number of times the light passes through the magnetic nanoparticle solution, and the relationship between n and the number of reflections m is: n = 2m + 1. It can be seen that when the number of reflections increases, the magneto-optical signal will also increase.

[0056] Example 3:

[0057] Compare the magneto-optical signals of magnetic nanoparticles with the same volume fraction and different particle sizes. Figure 4 The following are the experimental results when the particle size of magnetic nanoparticles is 30nm, 20nm, and 10nm, respectively, and distilled water is used as the control group. It can be seen that when the particle size increases, the magneto-optical signal will also increase.

[0058] Therefore, this magneto-optical immunoassay method based on optical liquid cavity can indeed improve the intensity of magneto-optical signals on the basis of magneto-optical immunoassay and increase the lower limit of detection concentration.

[0059] It will be easily understood by those skilled in the art that the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the present invention.

Claims

1. An immunoassay method, characterized in that: include: S1. causing the incident light to be reflected multiple times in the functional magnetic nanoparticle immunoassay reagent under the stimulation of an alternating magnetic field; S2. converting the emitted light after multiple reflections into a voltage signal and extracting the magneto-optical signal corresponding to the immunoassay reagent; S3. The immunoassay reagent is mixed with the test solution, so that the incident light is reflected multiple times in the mixed solution under the excitation of the AC magnetic field; the incident light and the AC magnetic field are the same as step S1; S4. converting the emitted light after multiple reflections into a voltage signal, and extracting the magneto-optical signal corresponding to the mixed solution; S5. When the difference between the magneto-optical signal corresponding to the immunoassay reagent and the magneto-optical signal corresponding to the mixed solution exceeds a preset threshold, it is determined that the test solution contains the target molecule to be tested. The magneto-optical signal is the ratio of the second harmonic component and the DC component in the voltage signal.

2. An immunoassay method according to claim 1, characterized in that: The method further includes passing the incident light through a polarizer to form horizontally polarized light.

3. An immunoassay method according to claim 1 or 2, characterized in that: The alternating magnetic field is perpendicular to the propagation direction of the incident light.

4. An immunoassay method according to claim 1, characterized in that: The incident light is a laser with a wavelength of 520 nm.

5. An immune detection system, characterized in that: include: lasers, polarizers, coils, optical fluid chambers, photodetectors, and computers; A laser for generating incident light; Polarizer, used to change the polarization direction of incident light; A coil for generating an AC excitation magnetic field; An optical liquid chamber is used to hold a functional magnetic nanoparticle immunoassay reagent or a mixed solution of an immunoassay reagent and a solution to be tested, so that the incident light is reflected multiple times in the functional magnetic nanoparticle immunoassay reagent or the mixed solution under the excitation of an alternating magnetic field; the structure of the optical liquid chamber is a cubic container with reflectors plated on the front and back surfaces; A photodetector, used to convert the outgoing light after multiple reflections into a voltage signal; A computer is used to extract magneto-optical signals corresponding to the immunoassay reagent and the mixed solution; when the difference between the magneto-optical signal corresponding to the immunoassay reagent and the magneto-optical signal corresponding to the mixed solution exceeds a preset threshold, it is determined that the test solution contains the target test molecule, and the magneto-optical signal is the ratio of the second harmonic component and the DC component in the voltage signal.

6. An immunoassay system according to claim 5, characterized in that: The AC excitation magnetic field generated by the coil is perpendicular to the propagation direction of the incident light generated by the laser.